 |
 |
|
Drug Discovery & Development of Innovative Therapeutics Japan 2009
Drug Discovery & Development of Innovative Therapeutics Japan 2009
|
|
June 01 - 03, 2009
Keio Plaza Hotel Shinjuku Tokyo, Japan
|
Choose your language:
|
Sponsors
Confirmed Sponsors
Updated: April 22, 2009
| Silver Sponsor |
 |
Invitrogen, part of Life Technologies Corporation, provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide. We provide essential life science technologies for disease research, drug discovery, and commercial bioproduction. Our research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, stem cells, cell therapy and cell biology -- placing Invitrogen products in nearly every major laboratory in the world. |
|
| Bronze Sponsors |
 |
After receiving official authorization as a RIKEN Venture Enterprise, Chiome Bioscience Inc. was established in 2005. Chiome is a solution provider to unmet medical needs by generating antibodies against tough antigens. Chiome has a very unique platform technology the “ADLib® System”. The “ADLib® System” can provide unparalleled speed for novel antibody generation and adaptability to diverse antigens. |
 |
Micromet, Inc. is a biopharmaceutical company with offices in Bethesdas/USA and Munich/Germany. The Company is developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmmune diseases. The Company uses its proprietary BiTE® antibody platform to create a new class of antibodies that specifically activate T cells from the patient's own immune system to eliminate cancer cells or other disease-related cells.
|
|
| Session and Technology Workshop Sponsors |
 |
GENEART is the solution provider for DNA engineering and processing. As the world wide leading supplier for synthetic genes, our services comprise integrated system solutions for development and production of improved DNA- and protein-based drugs and vaccines as well as improved enzymes and further biotech products. GENEART's service portfolio ranges from the production of optimized synthetic genes, gene variants and gene libraries in combinatorial biology right through to the production of DNA-based agents. |
 |
Genetix provides scientists and clinicians with unrivalled solutions for imaging and intelligent image analysis to facilitate development of pharmaceuticals and biotherapeutics, mainstream research, and clinical diagnostics. |
 |
GenScript is a contract research organization (CRO) specialized in drug discovery services. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. Founded in 2002 by seasoned pharmaceutical scientists, GenScript has become a leading Biology CRO with main operation in US and China, and subsidiaries in France and Japan. |
|
|
|
 |
|
| Refreshment/Coffee Break Sponsor |
 |
|
|
